Several gene variants predispose to NAFLD by enhancing fat accumulation in the liver, the most important of which is human patatin-like phospholipase domain-containing 3 (PNPLA3). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.